Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exposed amino groups on tissue proteins, primarily the epsilon-amino groups of lysine residues and N-terminal alpha-amino groups, are critical chemical sites for protein modification and cross-linking (Migneault et al., 2004, BioTechniques). In medical applications, these groups are the primary targets for glutaraldehyde, which forms covalent Schiff bases to stabilize bioprosthetic materials like heart valves, thereby reducing immunogenicity and increasing mechanical strength (Jayakrishnan & Jameela, 1996, Biomaterials). However, residual or unreacted amino groups in these tissues have been linked to pathological calcification, a major cause of bioprosthetic failure (Golomb et al., 1987, Am J Pathol). Furthermore, these amino groups are the sites for non-enzymatic glycation by reducing sugars, leading to the formation of advanced glycation end-products (AGEs) associated with diabetic complications and aging (Vistoli et al., 2013, Med Res Rev). While not a traditional biological target like a receptor, the chemical manipulation of these groups is essential for tissue engineering and the prevention of protein-related pathologies.
Covalent cross-linking or chemical modification of primary amines (lysine residues and N-termini) to stabilize protein structure, reduce immunogenicity, or prevent pathological glycation (Migneault et al., 2004; Jayakrishnan & Jameela, 1996).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exposed amino groups on tissue proteins.